Chronoscale Holdings Corp current report, 21 May 2025

Business Context and Reporting Period

This Form 8-K is filed by Ekso Bionics Holdings, Inc. (not Chronoscale Corp) on May 21, 2025. The filing reports on a corporate action regarding a reverse stock split approved by stockholders on May 16, 2025, and a subsequent change to its effective date.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.

Material Changes

  • Reverse Stock Split Ratio: The Board of Directors approved a 1-for-15 reverse stock split.
  • Effective Date Change: The effective time was changed from May 27, 2025, to June 2, 2025, at 12:01 a.m. PT.
  • Share Count Impact: Every 15 shares will be combined into 1 share. Fractional shares will be rounded up to the next whole share. The company expects approximately 2.4 million shares outstanding post-split.
  • Trading Details: The stock will continue to trade on the Nasdaq Capital Market under the symbol "EKSO" with a new CUSIP number of 282644 400.

Outlook, Risks, and Management Commentary

Purpose: The primary objective of the reverse stock split is to increase the price of the Company's common stock.

Regulatory Context: The action is a response to a notice received on December 12, 2024, from Nasdaq stating the Company failed to meet the minimum bid price requirement for listing on the Nasdaq Capital Market.

Scope: The split affects all issued and outstanding common stock, restricted stock units, stock options, and warrants.

Investor Verification Checklist

  • Verify the new effective date of June 2, 2025, for the 1-for-15 reverse stock split.
  • Confirm the new CUSIP number (282644 400) for post-split trading.
  • Review the Definitive Proxy Statement on Schedule 14A (filed April 10, 2025) for complete details on the proposal.
  • Monitor the stock price to ensure compliance with Nasdaq minimum bid price requirements following the split.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.